Drugs in Inflammation: Agents and Actions Supplements, cartea 32
Autor Michael Parnham, Michael A. Bray, Wim B. van den Bergen Limba Engleză Paperback – 17 noi 2012
Din seria Agents and Actions Supplements
- Preț: 392.23 lei
- Preț: 379.59 lei
- Preț: 377.13 lei
- Preț: 374.30 lei
- Preț: 375.26 lei
- Preț: 380.72 lei
- Preț: 391.64 lei
- Preț: 384.70 lei
- Preț: 379.96 lei
- Preț: 373.76 lei
- Preț: 376.38 lei
- Preț: 382.79 lei
- Preț: 383.00 lei
- Preț: 392.23 lei
- Preț: 389.03 lei
- 5% Preț: 385.69 lei
- Preț: 382.24 lei
- Preț: 378.83 lei
- Preț: 380.33 lei
- Preț: 384.49 lei
- 5% Preț: 706.62 lei
- 5% Preț: 357.21 lei
- 5% Preț: 359.54 lei
- Preț: 371.48 lei
- 5% Preț: 353.10 lei
- 5% Preț: 360.80 lei
Preț: 380.72 lei
Nou
Puncte Express: 571
Preț estimativ în valută:
72.89€ • 75.76$ • 60.43£
72.89€ • 75.76$ • 60.43£
Carte tipărită la comandă
Livrare economică 05-19 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783034874076
ISBN-10: 3034874073
Pagini: 264
Ilustrații: 260 p.
Dimensiuni: 170 x 244 x 14 mm
Greutate: 0.43 kg
Ediția:Softcover reprint of the original 1st ed. 1991
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Agents and Actions Supplements
Locul publicării:Basel, Switzerland
ISBN-10: 3034874073
Pagini: 264
Ilustrații: 260 p.
Dimensiuni: 170 x 244 x 14 mm
Greutate: 0.43 kg
Ediția:Softcover reprint of the original 1st ed. 1991
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Agents and Actions Supplements
Locul publicării:Basel, Switzerland
Public țintă
ResearchCuprins
Reducing the Side-Effects of Anti-Inflammatory Drugs.- Towards safer nonsteroidal anti-inflammatory drugs.- Developing nonsteroidal anti-inflammatory drugs (NSAIDs) with decreased gastrointestinal (GI) toxicity.- Anti-inflammatory efficacy and gastrointestinal irritancy: comparative 1 month repeat oral dose studies in the rat with nabumetone, ibuprofen and diclofenac.- A new anti-inflammatory agent (EGIS-5645) without gastrointestinal side-effect.- Antipyretic activity of tebufelone (NE-11740) in man.- Steroid-saving potency of nonsteroidal anti-inflammatory agents — a reevaluation with the new agent CGP 28238 in rat inflammatory models.- A biochemical investigation of auranofin nephrotoxicity by high field proton nuclear magnetic resonance (NMR) spectroscopy.- Influence of an intravenous dose of aurothiomalate on the status of low-molecular-mass endogenous metabolites in blood plasma: a proton nuclear magnetic resonance (NMR) study.- Influence of disodium aurothiomalate on the activities of xanthine dehydrogenase and xanthine oxidase in endothelial cells.- Application of a novel 1:1 gold (I)-chromophoric thiolate complex as a spectrophotometric probe for the thiol-exchange reactions of anti-arthritic gold drugs in biological fluids.- Effects of auranofin on endothelium dependent contractions in isolated rat aoria.- New Approaches to Pain Relief.- Electrophysiological mechanisms in inflammatory pain.- Molecular base of acetylcholine and morphine analgesia.- Prostaglandin (PG) modulation of bradykinin-induced hyperalgesia and oedema in the guinea-pig paw — effects of PGD2, PGE2 and PGI2.- Analgetic activity of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.- Pharmacological profile of flupirtine, a novel centrally acting, non-opioid analgesic drug.- Thepharmacological profile of aceclofenac, a new nonsteroidal anti-inflammatory and analgesic drug.- New Treatments for Bone and Cartilage Loss in Rheumatoid Arthritis.- Molecular basis of intracellular interactions in relation to bone and joint disease.- The role of proteinases in cartilage destruction.- Recognition of IL1-activated chondrocytes in porcine articular cartilage.- In vivo evidence for a key role of IL-1 in cartilage destruction in experimental arthritis.- An anti-CD4 antibody for treatment of chronic inflammatory arthritis.- Modulation of splenic lymphocyte activities by a new hypoxanthine derivative (ST 789) in immunosuppressed mice.- The newly developed neutrophil oxidative burst antagonist apocynin inhibits joint-swelling in rat collagen arthritis.- Auto-immune spondylodiscitis associated with collagen induced arthritis in rats: high field MRI findings.- Influence of muramyl dipeptide on established experimental arthritis in rats.- Selective inhibition by magnosalin and magnoshinin, compounds from “shin-I” (Flos magnoliae), of adjuvant-induced angiogenesis and granuloma formation in the mouse pouch.- Drug Modulation of Cytokine Production.- Cellular and molecular mechanisms of cytokine networking.- Anti-inflammatory properties of E5090, a novel orally active inhibitor of IL-1 generation.- A novel inhibitor of IL-1 generation, E5090: in vitro inhibitory effects on the generation of IL-1 by human monocytes.- A novel inhibitor of IL-1 generation, E5090: in vivo inhibitory effects on the generation of IL-1-like factor and on granuloma formation in an air-pouch model.- Lack of adjuvanticity of human recombinant interleukin-lß in collagen induced arthritis in rats.- Influence of azelastine on IL-1ß generation in vitro and IL-lß-induced effect in vivo.